These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Endothelial dysfunction: a global response]. López-Farré A; Farré J; Sánchez de Miguel L; Romero J; González-Fernández F; Casado S Rev Esp Cardiol; 1998; 51 Suppl 6():18-22. PubMed ID: 10050140 [TBL] [Abstract][Full Text] [Related]
64. Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism? Loscalzo J Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):3-5. PubMed ID: 12524215 [No Abstract] [Full Text] [Related]
65. More problems with the endothelium. Crossman DC QJM; 1997 Mar; 90(3):157-60. PubMed ID: 9093592 [No Abstract] [Full Text] [Related]
66. Atherogenesis--recent insights into basic mechanisms and their clinical impact. Schächinger V; Zeiher AM Nephrol Dial Transplant; 2002 Dec; 17(12):2055-64. PubMed ID: 12454211 [No Abstract] [Full Text] [Related]
67. Hypertension, aging, and atherosclerosis. The endothelial interface. Susic D Med Clin North Am; 1997 Sep; 81(5):1231-40. PubMed ID: 9308607 [TBL] [Abstract][Full Text] [Related]
68. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Henderson A Int J Cardiol; 1997 Dec; 62 Suppl 1():S43-8. PubMed ID: 9464583 [No Abstract] [Full Text] [Related]
69. Lipid metabolism: interactions of lipids and nitric oxide in the atherogenic process. Davidson J; Rotondo D Curr Opin Lipidol; 2005 Apr; 16(2):249-51. PubMed ID: 15767864 [No Abstract] [Full Text] [Related]
70. Endothelial cells, nitric oxide and ischaemic preconditioning. Parratt JR; Vegh A Basic Res Cardiol; 1996; 91(1):27-30. PubMed ID: 8660252 [No Abstract] [Full Text] [Related]
72. Nitric oxide and atherosclerosis: possible implications for therapy. Bult H Mol Med Today; 1996 Dec; 2(12):510-8. PubMed ID: 9015792 [TBL] [Abstract][Full Text] [Related]
73. Impairment of serotonin-mediated nitric oxide release across the coronary bed in patients with coronary spastic angina. Shimada T; Murakami Y; Hashimoto M; Ishibashi Y; Inoue S; Katoh H; Ishinaga Y; Masumura S Am J Cardiol; 1999 Mar; 83(6):953-5, A9. PubMed ID: 10190417 [TBL] [Abstract][Full Text] [Related]
74. C-reactive protein: a surrogate marker for atherosclerosis. Davidson J; Rotondo D Curr Opin Lipidol; 2004 Jun; 15(3):365-7. PubMed ID: 15166795 [No Abstract] [Full Text] [Related]
76. Aging of the vascular wall and atherogenesis: role of the elastin-laminin receptor. Robert L Atherosclerosis; 1996 Jun; 123(1-2):169-79. PubMed ID: 8782848 [TBL] [Abstract][Full Text] [Related]
77. Coronary vasospasm in humans: the role of atherosclerosis and of impaired endothelial vasodilator function. Ganz P; Weidinger FF; Yeung AC; Vekshtein VI; Vita JA; Ryan TJ; McLenachan JM; Selwyn AP Basic Res Cardiol; 1991; 86 Suppl 2():215-22. PubMed ID: 1953613 [No Abstract] [Full Text] [Related]
78. Nitric oxide puzzles and paradoxes in heart failure: how to fit the pieces together? Stewart DJ Clin Sci (Lond); 1998 Jan; 94(1):3-4. PubMed ID: 9505859 [No Abstract] [Full Text] [Related]
79. The role of nitric oxide in atherosclerosis. Maxwell AJ; Cooke JP Coron Artery Dis; 1999 Jul; 10(5):277-86. PubMed ID: 10421966 [No Abstract] [Full Text] [Related]
80. No fear of NO? Pittschieler K Acta Paediatr; 1999 May; 88(5):484-6. PubMed ID: 10426166 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]